Highlow study

 

METC 2012_347   ABR 40326  

 NL 40326.018.12  

NTR (Nederlands Trial Register) 3894  

NCT (Clinicaltrials.gov) 01828697


Low-molecular-weight heparin to prevent recurrent VTE in pregnancy: a randomized controlled trial of two doses


Click here  for the new ALEA randomization website




Number of inclusions

We are happy to announce that  918 patients have been enrolled since April 2013!



Netherlands: 436 patients (start: 1 April 2013)

France: 322 patients (start: 5 May 2015)

Ireland: 83 patients (start: 19 November 2015)

Belgium: 34 patients (start: 1 December 2015)

Norway: 27 patients (start: 15 February 2016)

USA: 4 patients (start: 25 July 2017)

Canada: 12 patients (start: 30 January 2018)



 

Are you a (international) physician willing to participate in this study? Please contact us at info@highlowstudy.org.